Complement plays an essential role in shock following intestinal ischaemia in rats

Clinical and Experimental Immunology

Volumn 106, Issue 1, 1996, Pages 156-159

  Ikai, M ^a   Itoh, M ^a   Joh, T ^a   Yokoyama, Y ^a   Okada, N ^a   Okada, H ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Carboxypeptidase; Cobra venom factor; Intestine; Ischaemia reperfusion; Shock

Indexed keywords

ANAPHYLATOXIN; CARBOXYPEPTIDASE; COBROTOXIN; COMPLEMENT;

ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; INTESTINE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK;

EID: 0029738623     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-817.x     Document Type: Article

References (22)

1. Filep J, Hermán F, Braquet P, Mózes T. Increased levels of platelet activating factor in blood following intestinal ischemia reperfusion in the dog. Biochem Biophys Res Commun 1989; 158:353 9.
2. Haglind E, Xia G, Rylander R. Effect of antioxidants and PAF receptor antagonist in intestinal shock in the rat. Circ Shock 1994; 42:83 91.
3. Kusche J, Lorenz W, Stahlknecht CD et al. Intestinal diamine oxidase and histamine release in rabbit mesenteric ischemia. Gastroenterology 1981; 80:980 7.
4. Haglund U. Gut ischemia. Gut 1994; 35:S73-76.
5. Parks DA. Bulkley GB, Gruger DN, Hamilton SR, McCord JM. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology 1982:82:9 15.
6. Hill J, Lindsay TF, Ortis F, Yeh CG, Hechtman HB, Moore Jr FD. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992; 149:1723 8.
7. Matsuo S, Ichidu S, Takizawa H, Okada N, Baranyi L, Iguchi A, Morgan BP, Okada H. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med 1994; 180:1619 27.
8. Huey R, Bloor CM, Kawahara MS, Hugli TE. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am J Pathol 1983; 112:48 60.
9. Plummer TH, Ryan TJ. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 1981; 98:448 54.
10. Lachmann PJ, Halbwachs L, Gewurz A, Gewurz H. Purification of cobra venom factor from phospholipase A contaminant. Immunology 1976; 31:961 8.
11. Alper CA, Balavitch D. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science 1976; 191:1275 6.
12. Müller-Eberhard HJ, Fjellström K. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J Immunol 1971; 107:1666 72.
13. Lesavre PH, Hugli TE, Esser AF, Müller-Eberhard HJ. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol 1979; 123:529 34.
14. Till GO, Johnson KJ, Kunkel R, Ward PA. Intravascular activation of complement and acute lung injury. J Clin Invest 1981; 69:1126.
15. Plummer HT, Hurwilz MY. Human plasma carboxypeptidase N: isolation and characterization. J Biol Chem 1978; 253:3907 12.
16. Erdös EG, Sloane EM. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol 1962; 11:585 92.
17. Bokisch VA. Müller-Eberhard HJ. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 1970; 49:2427 36.
18. Hugli TE. The structural basis for anaphylatoxin and chemotactic function of C3a, C4a, and C5a. Crit Rev Immunol 1981: 1:321 66.
19. Hendriks D, Scharpé S. van Sande M, Lommaert MP. Characterization of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 1989; 27:277 85.
20. Campbell W, Okada H. An arginine specific carhoxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem Biophys Res Commun 1989; 162:933 9.
21. Shinohara T, Sakurada C, Suzuki T, Takeuchi O, Campbell W, Ikeda S, Okada N, Okada H. Pro-carboxypeptidase R Cleaves bradykinin following activation. Int Arch Allergy Immunol 1994; 103:400 4.
22. Rabinovici R, Yeh CG, Hillegass LM, Griswold DE, Dimartino MJ, Vernick J, Fong KL, Feuerstein G. Role of complement in endotoxin/platelet-activating factor induced lung injury. J Immunol 1992; 149:1744 50.